Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP644036.RAYhh6CFJeb0KF3hN2Ff7jmCxIWHh3tqrvOtMFnt1pEUY130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644036.RAYhh6CFJeb0KF3hN2Ff7jmCxIWHh3tqrvOtMFnt1pEUY130_provenance.
• NP696464.RAV5I55YQ-JlqmJoJQ21wjwBAIlM2-9zVkSWPCDz5_qIc130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696464.RAV5I55YQ-JlqmJoJQ21wjwBAIlM2-9zVkSWPCDz5_qIc130_provenance.
• NP419188.RAEgdLA0xjo5IY6TRb_loguHA8bwsB2_bIPO4esDo8zVM130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419188.RAEgdLA0xjo5IY6TRb_loguHA8bwsB2_bIPO4esDo8zVM130_provenance.
• NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024838.RAB4WBogCAPY4FLBHbnpKvsS1qxyGecIBEgRdsHcB-sJE130_provenance.
• NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
• NP766417.RAaAQPnhohE88PDu7abPSNMbrVundGhdhNryCpRI1_8_A130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766417.RAaAQPnhohE88PDu7abPSNMbrVundGhdhNryCpRI1_8_A130_provenance.
• NP766436.RAToUmw8_0NJCIFtgv8ZFakscapcgcGO8xQH-N4SYfX6Q130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766436.RAToUmw8_0NJCIFtgv8ZFakscapcgcGO8xQH-N4SYfX6Q130_provenance.
• NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_provenance.
• NP766458.RAwhxQ6WvBGH3X6OJMEtR0heFv_6iUdeBUSisKgZQlkc0130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766458.RAwhxQ6WvBGH3X6OJMEtR0heFv_6iUdeBUSisKgZQlkc0130_provenance.
• assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1024836.RAr_WOkGanUH11H6HJjtbknq6lZ4fNWNNLtOII4ctQ99I130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024836.RAr_WOkGanUH11H6HJjtbknq6lZ4fNWNNLtOII4ctQ99I130_provenance.
• NP1024837.RAha5XrtqHQTTf9z3CAtCLNRE8EaFDUf5GlkrGxEUhPb8130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024837.RAha5XrtqHQTTf9z3CAtCLNRE8EaFDUf5GlkrGxEUhPb8130_provenance.